Boxer Capital, LLC - 13 Oct 2023 Form 4/A - Amendment Insider Report for Tango Therapeutics, Inc. (TNGX)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
17 Oct 2023, 19:41:18 UTC
Original report date
17 Oct 2023
Prior SEC filing
11 Oct 2023
Next SEC filing
25 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aaron I. Davis, Chief Executive Officer, MVA Investors, LLC

Key filing fact

Boxer Capital, LLC filed Form 4/A - Amendment for Tango Therapeutics, Inc. (TNGX) on 17 Oct 2023.

Key facts

  • This page summarizes Boxer Capital, LLC's Form 4/A - Amendment filing for Tango Therapeutics, Inc. (TNGX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Oct 2023, 19:41.

Change

  • Previous filing in this sequence was filed on 11 Oct 2023.
  • Current net transaction value: +$8,722,500.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNGX transaction

Common Stock

Purchase

Transaction value
$5,302,500
Shares
+750,000
Change %
+11%
Price
$7.07
Shares after
7,698,642
Date
13 Oct 2023
Ownership
Direct
Footnotes
F1, F3
TNGX transaction

Common Stock

Purchase

Transaction value
$3,420,000
Shares
+500,000
Change %
+6.5%
Price
$6.84
Shares after
8,198,642
Date
16 Oct 2023
Ownership
Direct
Footnotes
F2, F3
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
693,524
Date
13 Oct 2023
Ownership
See footnote
Footnotes
F4
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,000
Date
13 Oct 2023
Ownership
See footnote
Footnotes
F5
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26,961
Date
13 Oct 2023
Ownership
See footnote
Footnotes
F6
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,988,450
Date
13 Oct 2023
Ownership
See footnote
Footnotes
F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.10, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.54 to $7.01, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F3

These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

Footnote F4

These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

Footnote F5

These securities are owned directly by Mr. Davis. Each reporting person other than Mr. Davis disclaims beneficial ownership of these securities.

Footnote F6

These securities are owned directly by Braslyn Ltd. Mr. Lewis is the sole indirect own of Braslyn Ltd. Each reporting person other than Mr. Lewis disclaims beneficial ownership of these securities.

Footnote F7

These securities are owned directly by BCTG Holdings, LLC ("BCTG"). Boxer Capital is the majority member of BCTG and MVA Investors is a member of BCTG. Mr. Davis is a member of the investment committee of BCTG. Each reporting person disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

SEC remarks

The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share ("Common Stock"), of Tango Therapeutics, Inc. Boxer and Mr. Davis have informed the issuer that the purchases disclosed herein may give rise to profit subject to recovery by the issuer pursuant to Section 16(b) of the Securities Exchange Act of 1934. Without conceding the application of Section 16(b) of the Securities Exchange Act of 1934, Boxer and Mr. Davis have paid to the issuer the entire amount that would be recoverable by the issuer thereunder if the same is applicable to Boxer and Mr. Davis. As to any reporting person that is not a beneficial owner of more than 10% of the outstanding shares of Common Stock, this Form 4 shall not be deemed a concession that such person is subject to Section 16 of the Securities Exchange Act of 1934 with respect to the issuer. This Form 4/A amends and restates the Form 4 filed earlier on the same date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .